SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-122480
Filing Date
2019-04-26
Accepted
2019-04-26 16:34:02
Documents
7
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 NOTICE & ACCESS d719136ddefa14a.htm DEFA14A 36450
2 GRAPHIC g719136c1.jpg GRAPHIC 1751
3 GRAPHIC g719136c2.jpg GRAPHIC 1745
4 GRAPHIC g719136c3.jpg GRAPHIC 1766
5 GRAPHIC g719136x1.jpg GRAPHIC 3717
6 GRAPHIC g719136x2.jpg GRAPHIC 3753
7 GRAPHIC g719136x3.jpg GRAPHIC 3799
  Complete submission text file 0001193125-19-122480.txt   61036
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36183 | Film No.: 19772195
SIC: 2836 Biological Products, (No Diagnostic Substances)